NCCN Imaging Appropriate Use Criteria Integrating into MedCurrent's OrderWise Platform

November 8, 2016 — The National Comprehensive Cancer Network (NCCN) is collaborating with MedCurrent to integrate the NCCN Imaging Appropriate Use Criteria (NCCN Imaging AUC) into its clinical decision support (CDS) platform, OrderWise. The integration will allow access to imaging recommendations as derived from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines).

“Integration of NCCN Imaging AUC directly into the electronic healthcare workflow through OrderWise will benefit providers with point-of-care access to qualified, NCCN Guidelines-based imaging recommendations to assure quality care of patients with cancer,” said Robert W. Carlson, M.D., chief executive officer, NCCN.  “We welcome MedCurrent as an NCCN Health Information Technology (HIT) licensee and the opportunity to promote the standard of care set forth by expert NCCN Guidelines panels.”

Adapted from the NCCN Guidelines, NCCN Imaging AUC support clinical decision-making around the use of imaging in patients with cancer by outlining all imaging procedures recommended in the NCCN Guidelines. This includes radiographs, computed tomography (CT) scans, magnetic resonance imaging (MRI), functional nuclear medicine imaging like positron emission tomography (PET) and single photon emission computed tomography (SPECT), and ultrasound. NCCN is recognized by the Centers for Medicare & Medicaid Services (CMS) as an approved provider-led entity (PLE) for development of imaging AUC.

MedCurrent Chief Medical Officer Stephen Herman, M.D., said the integration will focus on workflow and structuring clinical content.

NCCN Imaging AUC are currently available for 12 NCCN Guidelines; the complete library of NCCN Imaging AUC will be available beginning Q2 2017. NCCN Imaging AUC are expected to be integrated into OrderWise in parallel and available immediately thereafter.

For more information: www.medcurrent.com